<DOC>
	<DOCNO>NCT02310750</DOCNO>
	<brief_summary>The main purpose study determine PF-06700841 safe well tolerate administer human . A secondary purpose ass body PF-06700841 assess PF-06700841 body give single multiple dos . The pharmacokinetic property different form PF-06700841 may study ( tablet solution/suspension form ) .</brief_summary>
	<brief_title>A Safety , Tolerability , Pharmacokinetics And Pharmacodynamics Study Of PF-06700841 , With Bioavailability/Food Effect Investigation</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Key Inclusion Criteria Healthy Subject Cohorts : Healthy male subject and/or female subject nonchildbearing potential age 18 55 year , inclusive No evidence active latent inadequately treated infection Mycobacterium tuberculosis ( TB ) Key Inclusion Criteria Psoriasis Subject Cohorts : Male subject and/or female subject nonchildbearing potential diagnosis plaque psoriasis age 18 65 year , inclusive Have diagnosis plaque psoriasis least 6 month prior first study dose Key Exclusion Criteria Healthy Subject Cohorts : Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) Males childbearing potential unwilling unable use highly effective method contraception outline protocol duration study least 28 day last dose investigational product Key Exclusion Criteria Psoriasis Subject Cohorts : Currently non plaque form psoriasis , ( eg , erythrodermic , guttate , pustular psoriasis ) . Have current drug induce psoriasis , eg , new onset psoriasis exacerbation psoriasis beta blocker , calcium channel blocker , antimalarial drug lithium Males childbearing potential unwilling unable use highly effective method contraception outline protocol duration study least 28 day last dose investigational product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>